Department of Pathology, Farhat Hached Hospital, Sousse 4000, Tunisia.
Pathol Oncol Res. 2012 Jul;18(3):691-6. doi: 10.1007/s12253-012-9496-x.
Osteosarcoma is a primary bone malignancy that typically occurs during adolescence but also has a second incidence peak in the elderly. The etiology of osteosarcoma is not well understood. Recent investigations have identified SV40 DNA sequences in osteosarcomas, suggesting that SV40 may contribute to tumor development. However, these studies also demonstrated geographical differences in SV40-positive osteosarcomas. The purpose of this study was to determine the prevalence and clinicopathological characteristics of SV40 positive osteosarcoma in Tunisian patients. Fifty-six formalin-fixed paraffin-embedded specimens of osteosarcomas were retrospectively investigated. Samples investigated were clinical cases examined between 1990 and 2004 in the Laboratory of Pathology at the University Hospital Farhat-Hached of Sousse (Tunisia). The search for SV40 was performed by immunohistochemistry using the Pab108 antibody for the detection of the viral oncoproteins: large T antigen and small t antigen (T/t-ag). SV40 status was correlated with clinico-pathological data. T/t-ag immunostaning was detected in the tumor cells in 31/56 (55.4%) osteosarcoma cases. SV40 positivity was more frequent (83%) in patients older than 40 years (5/6 cases) than in patients under 40 years (52%, 26/50), but the difference does not reach statistical significance (p = 0.33). Moreover, the time between the onset of clinical symptoms and diagnosis was shorter for SV40 positive than SV40 negative cases (p = 0.08). However, the viral status did not differ significantly according to gender, tumor size, histological subtype, tumor location, or metastases. This study documents the presence SV40 T/t-antigens in a proportion of osteosarcomas in Tunisian patients. The expression of these viral oncoproteins supports the hypothesis that SV40 may have a role in the pathogenesis of this tumor.
骨肉瘤是一种主要的骨恶性肿瘤,通常发生在青少年时期,但也有第二个发病高峰在老年人。骨肉瘤的病因尚不清楚。最近的研究已经在骨肉瘤中发现了 SV40 DNA 序列,表明 SV40 可能有助于肿瘤的发展。然而,这些研究也表明 SV40 阳性骨肉瘤存在地理差异。本研究旨在确定 SV40 阳性骨肉瘤在突尼斯患者中的流行率和临床病理特征。回顾性研究了 56 例福尔马林固定石蜡包埋的骨肉瘤标本。研究的样本是 1990 年至 2004 年期间在苏塞法哈特哈奇大学医院病理学实验室检查的临床病例。使用 Pab108 抗体通过免疫组织化学检测病毒癌蛋白:大 T 抗原和小 t 抗原(T/t-ag)来检测 SV40。SV40 状态与临床病理数据相关。在 56 例骨肉瘤病例中,有 31 例(55.4%)肿瘤细胞中检测到 T/t-ag 免疫染色。40 岁以上患者的 SV40 阳性率(83%,5/6 例)高于 40 岁以下患者(52%,26/50 例),但差异无统计学意义(p=0.33)。此外,SV40 阳性病例的临床症状出现至诊断的时间短于 SV40 阴性病例(p=0.08)。然而,病毒状态与性别、肿瘤大小、组织学亚型、肿瘤位置或转移无显著差异。本研究证明了 SV40 T/t-抗原在突尼斯患者骨肉瘤中的存在。这些病毒癌蛋白的表达支持了 SV40 可能在这种肿瘤的发病机制中起作用的假设。